ICU Medical, Inc. (NASDAQ:ICUI) Q4 2025 Earnings Call Transcript February 20, 2026 Operator: Good day, and welcome to the ICU Medical, Inc. Fourth Quarter 2025 Earnings Conference Call. [Operator ...

ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results ...

SAN CLEMENTE, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial ...

CONROE, Texas, Feb. 10, 2026 /PRNewswire/ -- Next Level Medical will host a ribbon cutting ceremony on Tuesday, February 17, 2026, from 10:00 a.m. to 11:00 a.m., in partnership with the Conroe/Lake ...

She was absolutely, utterly exhausted. It was the morning of Christmas Eve, and her kids, almost 4 and 2, woke her up “way too early,” excited for the holiday. A so-so night’s sleep didn’t help the ...

CORPUS CHRISTI, Texas — If Corpus Christi enters a Level 1 water emergency, city water customers would face significant curtailment measures that would drastically reduce water availability. According ...

Amazon is rolling out an artificial intelligence health-care tool for One Medical members, called Health AI. The service uses large language models and references patients medical records to answer ...

Detailed price information for I C U Medical Inc (ICUI-Q) from The Globe and Mail including charting and trades.

Section 1. Purpose and Policy. Americans deserve access to the best medical treatments and research infrastructure in the world. In 2023, the Food and Drug Administration (FDA) completed a review of ...

RECOGNIZING AND IMPROVING KNOWLEDGE OF MEDICAL USES OF MARIJUANA AND CANNABIDIOL FOR PATIENTS AND DOCTORS: Today, President Donald J. Trump signed an Executive Order that will improve medical ...

To return 'large portion' of sale proceeds to shareholders Panmure says price tag at the top end of market expectations Deal expected to close in second half of 2026, pending approvals Dec 3 (Reuters) ...